These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 31065657

  • 1. A dual-functional molecular strategy for in situ suppressing and visualizing of neuraminidase in aqueous solution using iridium(iii) complexes.
    Wu C, Wu KJ, Liu JB, Zhou XM, Leung CH, Ma DL.
    Chem Commun (Camb); 2019 May 30; 55(45):6353-6356. PubMed ID: 31065657
    [Abstract] [Full Text] [Related]

  • 2. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J, Yang X, Xu M, Chan PK, Ma C.
    Eur J Med Chem; 2019 Nov 15; 182():111635. PubMed ID: 31493744
    [Abstract] [Full Text] [Related]

  • 3. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M, Martin SR, Birge M, Carbain B, Streicher H.
    Org Biomol Chem; 2011 Aug 21; 9(16):5625-9. PubMed ID: 21720632
    [Abstract] [Full Text] [Related]

  • 4. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
    Yan ZL, Liu AY, Wei XX, Zhang Z, Qin L, Yu Q, Yu P, Lu K, Yang Y.
    Carbohydr Res; 2019 May 15; 477():32-38. PubMed ID: 30954773
    [Abstract] [Full Text] [Related]

  • 5. A phospha-oseltamivir-biotin conjugate as a strong and selective adhesive for the influenza virus.
    Streicher H, Martin SR, Coombs PJ, McCauley J, Neill-Hall D, Stanley M.
    Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1805-7. PubMed ID: 24594352
    [Abstract] [Full Text] [Related]

  • 6. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E, Ye D, Li J, Zhang D, Wang J, Zhao F, Hilgenfeld R, Zheng M, Jiang H, Liu H.
    ChemMedChem; 2012 Sep 01; 7(9):1527-36. PubMed ID: 22807317
    [Abstract] [Full Text] [Related]

  • 7. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
    Jia R, Zhang J, Bertagnin C, Cherukupalli S, Ai W, Ding X, Li Z, Zhang J, Ju H, Ma X, Loregian A, Huang B, Zhan P, Liu X.
    Eur J Med Chem; 2021 Feb 15; 212():113097. PubMed ID: 33385836
    [Abstract] [Full Text] [Related]

  • 8. Discovery of novel acylhydrazone neuraminidase inhibitors.
    Zhao ZX, Cheng LP, Li M, Pang W, Wu FH.
    Eur J Med Chem; 2019 Jul 01; 173():305-313. PubMed ID: 31022584
    [Abstract] [Full Text] [Related]

  • 9. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
    Enkhtaivan G, Muthuraman P, Kim DH, Mistry B.
    Bioorg Med Chem; 2017 Oct 15; 25(20):5185-5193. PubMed ID: 28958846
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of NH2-acyl oseltamivir analogues as potent neuraminidase inhibitors.
    Wang K, Yang F, Wang L, Liu K, Sun L, Lin B, Hu Y, Wang B, Cheng M, Tian Y.
    Eur J Med Chem; 2017 Dec 01; 141():648-656. PubMed ID: 29107426
    [Abstract] [Full Text] [Related]

  • 11. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
    Hong BT, Chen CL, Fang JM, Tsai KC, Wang SY, Huang WI, Cheng YE, Wong CH.
    Bioorg Med Chem; 2014 Dec 01; 22(23):6647-6654. PubMed ID: 25456388
    [Abstract] [Full Text] [Related]

  • 12. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.
    Gong J, Xu W.
    Curr Med Chem; 2008 Dec 01; 15(30):3145-59. PubMed ID: 19075659
    [Abstract] [Full Text] [Related]

  • 13. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM, García-Machorro J, Méndez-Luna D, Tolentino-López LE, Martínez-Ramos F, Padilla-Martínez II, Aguilar-Faisal L, Soriano-Ursúa MA, Trujillo-Ferrara JG, Fragoso-Vázquez MJ, Barrón BL, Correa-Basurto J.
    Eur J Med Chem; 2017 Mar 10; 128():154-167. PubMed ID: 28182988
    [Abstract] [Full Text] [Related]

  • 14. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.
    Somasundaram B, Fee CJ, Fredericks R, Watson AJ, Fairbanks AJ, Hall RJ.
    J Mol Recognit; 2015 Sep 10; 28(9):521-7. PubMed ID: 25727669
    [Abstract] [Full Text] [Related]

  • 15. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
    Ai W, Zhang J, Zalloum WA, Jia R, Cherukupalli S, Ding X, Sun Z, Sun L, Jiang X, Ma X, Li Z, Wang D, Huang B, Zhan P, Liu X.
    Eur J Med Chem; 2020 Apr 01; 191():112147. PubMed ID: 32092589
    [Abstract] [Full Text] [Related]

  • 16. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J.
    Chem Rev; 2009 Sep 01; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
    Ju H, Zhang J, Sun Z, Huang Z, Qi W, Huang B, Zhan P, Liu X.
    Eur J Med Chem; 2018 Feb 25; 146():220-231. PubMed ID: 29407952
    [Abstract] [Full Text] [Related]

  • 18. Tamiphosphor monoesters as effective anti-influenza agents.
    Chen CL, Lin TC, Wang SY, Shie JJ, Tsai KC, Cheng YS, Jan JT, Lin CJ, Fang JM, Wong CH.
    Eur J Med Chem; 2014 Jun 23; 81():106-18. PubMed ID: 24836064
    [Abstract] [Full Text] [Related]

  • 19. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T, Malaisree M, Udommaneethanakit T, Hannongbua S.
    Biophys Chem; 2009 Apr 23; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract] [Full Text] [Related]

  • 20. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S, De-Eknamkul W.
    Expert Opin Ther Pat; 2013 Apr 23; 23(4):409-23. PubMed ID: 23369206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.